Cybin, Inc. (HELP)
12.37
-1.65
(-11.77%)
USD |
NASDAQ |
Sep 18, 16:00
12.64
+0.27
(+2.18%)
Pre-Market: 08:59
Cybin Net Income (Quarterly) : -47.82M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -47.82M |
| March 31, 2026 | -47.00M |
| December 31, 2025 | -42.67M |
| September 30, 2025 | -33.72M |
| June 30, 2025 | -24.61M |
| March 31, 2025 | -21.31M |
| December 31, 2024 | -7.538M |
| September 30, 2024 | -41.93M |
| June 30, 2024 | -10.83M |
| March 31, 2024 | -15.83M |
| December 31, 2023 | -22.27M |
| September 30, 2023 | -8.865M |
| June 30, 2023 | -10.81M |
| March 31, 2023 | -10.14M |
| December 31, 2022 | -7.912M |
| September 30, 2022 | -7.636M |
| Date | Value |
|---|---|
| June 30, 2022 | -10.22M |
| March 31, 2022 | -14.29M |
| December 31, 2021 | -13.65M |
| September 30, 2021 | -13.97M |
| June 30, 2021 | -11.99M |
| March 31, 2021 | -10.88M |
| December 31, 2020 | -8.763M |
| July 31, 2019 | -0.0156M |
| April 30, 2019 | -0.0319M |
| January 31, 2019 | -0.0078M |
| October 31, 2018 | -0.0208M |
| July 31, 2018 | -0.0474M |
| April 30, 2018 | -0.0068M |
| January 31, 2018 | -0.1151M |
| October 31, 2017 | -0.004M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Atai Beckley, Inc. | -32.55M |
| Clearmind Medicine, Inc. | -0.9073M |
| InMed Pharmaceuticals, Inc. | -4.843M |
| NervGen Pharma Corp. | -21.10M |
| Milestone Pharmaceuticals, Inc. | -28.61M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 47.82M |
| EPS Diluted (Quarterly) | -0.914 |
| Enterprise Value | 600.38M |
| Earnings Yield | -34.32% |
| Normalized Earnings Yield | -33.07 |